MUPHORAN, powder and solution for parenteral use for dilution (infusion) bottle, 4 ml
Active ingredients: Fotemustine
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solution for parenteral use for dilutionbottle, 4 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MUPHORAN, poudre et solution pour usage parentéral à diluer (perfusion)
- Pharmaceutical form
- poudre et solution pour usage parentéral à diluer
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre brun de 208 mg - 1 ampoule(s) en verre de 4 ml
- Marketing authorisation holder
- LES LABORATOIRES SERVIER
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Jun 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63675185CIP73318702CIP133400933187026Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FOTÉMUSTINEpoudre | 208 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.